A Phase I Study to Investigate Tolerability and Efficacy of Autologous Lymphoid Effector Cells Specific Against Tumour-cells (ALECSAT) Administered to Patients With Glioblastoma Multiforme (GBM)
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Cancer vaccine-ALECSAT (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 May 2012 New trial record